




Structural investigation of gp36-MPER 
in membrane mimicking systems 
 
Abstract 
FIV is a lentivirus that resembles the Human Immunodeficiency Virus 
(HIV). The lentiviral envelope glycoproteins (gp41 in HIV and gp36 in FIV) 
mediate virus entry by interacting with specific receptors present at the cell 
surface. Increasing evidences suggest a common structural framework for 
these glycoproteins, corresponding to similar roles in virus cell fusion.
 
During 
the virus entry a conformational transition occurs in the glycoproteins to form 
a stable six-helical bundle. In this conformational arrangement, the correct 
assembly with the membrane of a tryptophan (Trp) rich region named 
membrane proximal external region (MPER) leads to the fusion of virus 
envelope and host cell membrane. The design of molecules inhibiting the 
correct positioning of MPER on the membrane is currently a strategy for the 
design of virus entry inhibitors.  
C8, a Trp-rich fragment of gp36-MPER, was identified as an antiviral 
compound inhibiting the entry of FIV into the host cell. C8 showed 
remarkable membrane binding property, inducing alteration of the 
phospholipid bilayer and membrane fusion. In this context, part of my PhD 
thesis is focused on the study of C8/lipid membrane interaction employing a 
multiscale approach based on spectroscopic experiments, molecular dynamics 
simulations and confocal microscopy imaging. Our results show that the 





structural reorganization of the phospholipid bilayer that finally leads to the 
formation of membrane tubules.  
The presence and the position of Trp residues in C8 are important for 




 residues, exhibits conserved antiviral activity, while the C8 





nearly inactive. To elucidate the structural factors that induce the different 
activity profiles of C6a and C6b, in spite of their similarity, in the second part 
of my PhD thesis I performed the study of structural behaviour of the two 
peptides in membrane mimicking environments using an analytical approach 
very similar to that employed for C8 peptide. I analysed C6a and C6b using 
CD and NMR spectroscopy, and confocal microscopy imaging. These data 
provide evidence that common antiviral activity profiles correspond to similar 
membrane binding properties: actually C6a, similarly to C8, has the ability to 
destabilize membrane vesicles, producing complex network of membrane 
tubes.  
Eventually, I analyzed structural behavior of the full gp36-CHR-MPER in a 
set of membrane models characterized by increased complexity: micelles, 
multilamellar vesicles and cellular vesicles. Analyses with paramagnetic 
probes and confocal microscopy indicate that gp36-CHR-MPER and its 
derivatives are active on each of the mentioned bio-membrane systems, thus 
indicating that their impact on the size and shape is not a biophysical artefact, 
but an effect of biological relevance.  
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